Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on Thursday as he challenged the prevailing pessimism among some on Wall Street.
Keep Reading →
March 30 - Hedge Funds, News
After being in the green for a few trading sessions, the broader market index slid 0.8% on Wednesday, and blue-chip companies declined 0.1%.
Keep Reading →
March 26 - Insider Trading, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer reiterated that the Trump administration has to clarify its narrative about tariffs to convince the average American...
Keep Reading →
March 19 - News
After two years of 25%+ gains, some investors worry that stocks are overvalued.
Keep Reading →
March 15 - Hedge Funds, News
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Keep Reading →
March 15 - Hedge Funds, News
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
Keep Reading →
March 14 - Hedge Funds, News
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Keep Reading →
March 11 - Hedge Funds, Industries, News
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Keep Reading →
February 22 - Hedge Funds, News
Jim Cramer, the host of Mad Money, has been considering the uncertainty surrounding 2025 and the ongoing macroeconomic challenges that are sparking important questions.
Keep Reading →
January 30 - Hedge Funds, News
Healthcare has been one of Jim Cramer's favorite topics lately.
Keep Reading →
December 31 - News
In his second appearance on Squawk on the Street after the Fed's interest rate cut, Jim Cramer had a lot to say about the Fed's decision and the Personal Consumption Expenditure...
Keep Reading →
December 24 - News
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
Keep Reading →
December 24 - Hedge Funds, News
The Federal Reserve created quite a bit of turmoil in the stock market on Wednesday when despite cutting interest rates, it signaled to investors that the journey to low rates...
Keep Reading →
December 23 - News
Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with cult stocks, which in hindsight appear to be clear success...
Keep Reading →
December 18 - Hedge Funds, News
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Keep Reading →
November 20 - News
Renaissance Technologies is an American hedge fund that specializes in systematic trading and employs statistical and mathematical tools to drive its investment programs.
Keep Reading →
October 6 - Hedge Funds, News
As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1," the size of the global biotechnology industry was assessed to be worth $1.38 trillion in 2023 and...
Keep Reading →
September 5 - Industries, News
In this article, we are going to discuss the 10 best healthcare stocks to buy according to hedge funds.
Keep Reading →
June 24 - Hedge Funds, News
We recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from Mega-Cap Tech and AI Stocks. Since Vertex Pharmaceuticals Incorporated (NASDAQ...
Keep Reading →
June 19 - Hedge Funds, News
Venu Krishna, Head of U.S.
Keep Reading →
June 18 - Hedge Funds, News
With the passage of time, the role of women in the modern day workplace has slowly started to grow.
Keep Reading →
June 14 - Hedge Funds, News
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading...
Keep Reading →
June 3 - Hedge Funds
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
Keep Reading →
June 3 - Hedge Funds, News, Stock Analysis
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Keep Reading →
May 8 - Market Movers, News
In this article, we discuss the 23 most profitable stocks of the last 12 months.
Keep Reading →
May 4 - Hedge Funds, News
In this article, we will be taking a look at the 5 biggest biotechnology companies in the world.
Keep Reading →
March 17 - News
In this article, we will take a look at the 5 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Keep Reading →
February 23 - Lists, News
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
Keep Reading →
February 17 - Hedge Funds, News
In this article, we discuss the top 5 CRISPR stocks to invest in.
Keep Reading →
February 10 - News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.
Keep Reading →
January 22 - Hedge Funds, News
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
Keep Reading →
December 20 - Hedge Funds, News
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Keep Reading →
December 12 - Industries, Lists, News
In this article, we discuss Jim Simons and his top 10 stock picks.
Keep Reading →
December 8 - Hedge Funds, News
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Keep Reading →
November 16 - Hedge Funds, News
In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this piece, we will take a look at the 12 best low beta stocks to buy.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Keep Reading →
November 9 - Industries, Lists, News
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Keep Reading →
October 20 - Hedge Funds
In this article, we discuss 5 DNA stocks that billionaires love.
Keep Reading →
June 14 - Hedge Funds, News
In this article, we take a look at 27 largest biotech companies in the US.
Keep Reading →
April 29 - Lists, News
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Keep Reading →
April 26 - Hedge Funds, News
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming.
Keep Reading →
April 20 - Hedge Funds, News
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
Keep Reading →
January 21 - Hedge Funds, News
Below we take a look at Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks.
Keep Reading →
December 31 - Hedge Funds, News
In this article, we discuss the 5 biotech stocks with the biggest upside.
Keep Reading →
December 13 - Hedge Funds, News
All three key U.S. indices jumped this morning, thanks to better-than-expected earnings of giants like Apple Inc.
Keep Reading →
October 28 - News
Cardinal Health, Inc. (NYSE:CAH) offers investors a forward dividend yield of 2.91% as of October 21.
Keep Reading →
October 24 - Hedge Funds, News
Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California.
Keep Reading →
October 14 - Hedge Funds, News